| S1792 |
Simvastatin (MK-733)
|
Simvastatin is a competitive inhibitor of HMG-CoA reductase with Ki of 0.1-0.2 nM in cell-free assays. Simvastatin induces ferroptosis, mitophagy, autophagy and apoptosis.
|
-
Nat Metab, 2025, 7(10):2018-2032
-
Cancer Commun (Lond), 2025, 10.1002/cac2.70036
-
J Clin Invest, 2025, e190215
|
|
| S1759 |
Pitavastatin (NK-104) Calcium
|
Pitavastatin calcium, a novel member of the medication class of statins, is a calcium salt formulation of pitavastatin which is a highly effective HMG-CoA reductase inhibitor. Pitavastatin Calcium attenuates AGEs-induced mitophagy via inhibition of ROS generation. Pitavastatin Calcium induces autophagy and apoptosis.
|
-
bioRxiv, 2025, 2025.08.10.669191
-
Nat Commun, 2024, 15(1):4099
-
J Immunother Cancer, 2024, 12(11)e009805
|
|
| S3036 |
Pravastatin (CS-514) Sodium
|
Pravastatin sodium (CS-514) is an HMG-CoA Reductase inhibitor against sterol synthesis with IC50 of 5.6 μM.
|
-
Int J Mol Sci, 2023, 24(7)6500
-
J Cosmet Dermatol, 2022, 10.1111/jocd.15142
-
Nat Biotechnol, 2021, 10.1038/s41587-021-00860-4
|
|
| S2061 |
Lovastatin (Mevinolin, MK-803)
|
Lovastatin is an inhibitor of HMG-CoA reductase with IC50 of 3.4 nM in a cell-free assay, used for lowering cholesterol (hypolipidaemic agent). Lovastatin triggers autophagy.
|
-
J Clin Invest, 2025, e190215
-
Redox Biol, 2025, 84:103693
-
PLoS Pathog, 2025, 21(10):e1013558
|
|
| S5715 |
Atorvastatin
|
Atorvastatin is a lipid lowering agent. It is a competitive inhibitor of hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase, the rate-determining enzyme in cholesterol biosynthesis via the mevalonate pathway. Atorvastatin activates autophagy.
|
-
Cell, 2025, S0092-8674(25)00751-2
-
Cell Stem Cell, 2025, S1934-5909(25)00265-6
-
Pigment Cell Melanoma Res, 2025, 38(3):e70021
|
|
| S1909 |
Fluvastatin Sodium
|
Fluvastatin Sodium inhibits HMG-CoA reductase activity with IC50 of 8 nM in a cell-free assay.
|
-
J Immunother Cancer, 2024, 12(11)e009805
-
Oncogene, 2022, 41(39):4446-4458
-
iScience, 2022, 25(10):105068
|
|
| S2169 |
Rosuvastatin calcium
|
Rosuvastatin calcium is a competitive inhibitor of HMG-CoA reductase with IC50 of 11 nM in a cell-free assay.
|
-
Biochem Pharmacol, 2025, 241:117171
-
J Immunother Cancer, 2024, 12(11)e009805
-
JCI Insight, 2024, 9(24)e178535
|
|
| S2077 |
Atorvastatin Calcium (CI-981)
|
Atorvastatin Calcium is an inhibitor of HMG-CoA reductase used as a cholesterol-lowering medication that blocks the production of cholesterol. Atorvastatin Calcium induces apoptosis and autophagy.
|
-
J Exp Clin Cancer Res, 2025, 44(1):317
-
Cell Rep, 2025, 44(6):115792
-
Pharmaceutics, 2025, 17(5)557
|
|
| S4223 |
Mevastatin
|
Mevastatin (ML-236B, Compactin) is a competitive inhibitor of HMG-Coenzyme A (HMG-CoA) reductase with a binding affinity 10,000 times greater than the HMG-CoA substrate itself.
|
-
J Immunother Cancer, 2024, 12(11)e009805
-
Nat Cardiovasc Res, 2023, 2(6):550-571
-
Immunity, 2021, 54(10):2273-2287.e6
|
|
| S5713 |
Pravastatin
|
Pravastatin(CS-514) is a lipoprotein-lowering drug via reversibly inhibiting hydroxymethylglutaryl-CoA (HMG-CoA) reductase and the synthesis of very-low-density lipoproteins.
|
-
EMBO Rep, 2022, e53373
-
Biomedicines, 2022, 10(9)2123
-
Front Cardiovasc Med, 2022, 9:921829
|
|